206 related articles for article (PubMed ID: 33049000)
1. IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection.
Montes de Oca M; de Labastida Rivera F; Winterford C; Frame TCM; Ng SS; Amante FH; Edwards CL; Bukali L; Wang Y; Uzonna JE; Kuns RD; Zhang P; Kabat A; Klein Geltink RI; Pearce EJ; Hill GR; Engwerda CR
PLoS Pathog; 2020 Oct; 16(10):e1008994. PubMed ID: 33049000
[TBL] [Abstract][Full Text] [Related]
2. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
3. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
Melby PC; Yang YZ; Cheng J; Zhao W
Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834
[TBL] [Abstract][Full Text] [Related]
4. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
5. A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.
Edwards CL; Engel JA; de Labastida Rivera F; Ng SS; Corvino D; Montes de Oca M; Frame TC; Chauhan SB; Singh SS; Kumar A; Wang Y; Na J; Mukhopadhyay P; Lee JS; Nylen S; Sundar S; Kumar R; Engwerda CR
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37917177
[TBL] [Abstract][Full Text] [Related]
6. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
[TBL] [Abstract][Full Text] [Related]
7. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
8. Distinct Roles for CD4
Bunn PT; Montes de Oca M; de Labastida Rivera F; Kumar R; Ng SS; Edwards CL; Faleiro RJ; Sheel M; Amante FH; Frame TCM; Muller W; Haque A; Uzonna JE; Hill GR; Engwerda CR
J Immunol; 2018 Dec; 201(11):3362-3372. PubMed ID: 30355785
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis.
Hammami A; Abidin BM; Heinonen KM; Stäger S
Sci Rep; 2018 Feb; 8(1):3500. PubMed ID: 29472618
[TBL] [Abstract][Full Text] [Related]
10. Combined Immune Therapy for the Treatment of Visceral Leishmaniasis.
Faleiro RJ; Kumar R; Bunn PT; Singh N; Chauhan SB; Sheel M; Amante FH; Montes de Oca M; Edwards CL; Ng SS; Best SE; Haque A; Beattie L; Hafner LM; Sacks D; Nylen S; Sundar S; Engwerda CR
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004415. PubMed ID: 26872334
[TBL] [Abstract][Full Text] [Related]
11. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.
Paun A; Bankoti R; Joshi T; Pitha PM; Stäger S
PLoS Pathog; 2011 Jan; 7(1):e1001246. PubMed ID: 21253574
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 Deficiency Promotes the Early Th1 Immune Response and Resistance toward Visceral Leishmaniasis.
Varikuti S; Verma C; Holcomb E; Jha BK; Viana A; Maryala R; Lamenza F; McElwain BK; Doni NY; Papenfuss T; Oghumu S; Gannavaram S; Nakhasi HL; Satoskar AR
J Immunol; 2021 Sep; 207(5):1322-1332. PubMed ID: 34341171
[TBL] [Abstract][Full Text] [Related]
13. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
14. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.
Melby PC; Chandrasekar B; Zhao W; Coe JE
J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
[TBL] [Abstract][Full Text] [Related]
16. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
[TBL] [Abstract][Full Text] [Related]
17. Centrin-Deleted
Singh RK; Gannavaram S; Ismail N; Kaul A; Gedda MR; Nakhasi HL
Front Immunol; 2018; 9():1176. PubMed ID: 29915577
[TBL] [Abstract][Full Text] [Related]
18. Live Attenuated
Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
[TBL] [Abstract][Full Text] [Related]
19. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
20. Differential Role of Leptin as an Immunomodulator in Controlling Visceral Leishmaniasis in Normal and Leptin-Deficient Mice.
Maurya R; Bhattacharya P; Ismail N; Dagur PK; Joshi AB; Razdan K; McCoy JP; Ascher J; Dey R; Nakhasi HL
Am J Trop Med Hyg; 2016 Jul; 95(1):109-119. PubMed ID: 27114296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]